stockrow
Friday 6 November 2026
Export LQDA’s income statement to Excel — free account
Liquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
44.69
2.69
−5.68%
Follow LQDA
Alert me
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | — | 4 | — | 6 | — | 4 | 2 | 1 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(4.42) | (4.11) | (3.06) | (3.15) | 0.11 | (0.38) | 2.19 | 0.35 | (0.64) | 4.08 |
P/S ratio |
8.03 | 8.25 | 10.15 | 10.32 | 18.82 | 19.87 | 23.30 | 42.85 | 66.13 | 18.75 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(9.92) | (10.71) | (6.79) | (9.32) | (7.01) | (5.80) | (3.79) | (11.33) | (6.79) | (4.36) |
Beneish M-Score |
— | — | — | — | (2.62) | — | (2.62) | (4.52) | (3.57) | 6.79 |
P/Operating CF |
(5.63) | (5.78) | (7.10) | (7.22) | (32.01) | (33.78) | (80.65) | (46.89) | (44.47) | 67.09 |
P/B ratio |
2.26 | 2.33 | 1.41 | 1.43 | 3.71 | 3.91 | 4.11 | 15.85 | 11.66 | 66.33 |
Price to Tangible BV |
2.26 | 2.33 | 1.62 | 1.65 | 4.25 | 4.48 | 4.48 | 18.75 | 12.80 | 78.33 |
EV/Sales |
4.08 | 4.31 | 5.15 | 5.33 | 15.27 | 16.32 | 18.77 | 40.70 | 61.62 | 18.75 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.83) | (0.88) | (0.94) | (0.97) | (5.77) | (6.16) | (10.46) | (17.12) | (9.23) | (83.19) |
EV/FCF |
(0.80) | (0.85) | (0.93) | (0.96) | (5.75) | (6.14) | (10.24) | (16.61) | (8.77) | (74.18) |
Quick Ratio |
3.31 | 5.56 | 5.56 | 8.26 | 8.25 | 11.17 | 11.17 | 4.73 | 4.29 | 1.80 |
Current Ratio |
3.34 | 5.63 | 5.63 | 8.36 | 8.36 | 11.34 | 11.34 | 4.85 | 4.43 | 2.01 |
Net Debt/EBITDA |
0.88 | 0.00 | 0.98 | 0.00 | 1.66 | 0.00 | 2.09 | 0.53 | 0.53 | (0.01) |
Debt/Assets |
24.60% | 0.00% | 10.60% | 0.00% | 11.48% | 0.00% | 15.52% | 38.90% | 49.19% | 58.35% |
Debt/Equity |
0.48 | 0.00 | 0.15 | 0.00 | 0.16 | 0.00 | 0.22 | 0.97 | 1.43 | 4.28 |
Asset Turnover |
0.14 | 0.00 | 0.01 | 0.00 | 0.13 | 0.00 | 0.14 | 0.14 | 0.08 | 0.57 |
Operating CF/Net income |
1.01 | 0.91 | 0.91 | 0.98 | 0.98 | 0.70 | 0.70 | 0.53 | 0.73 | 0.52 |
Capex/Depreciation |
(0.70) | 0.00 | (0.24) | 0.00 | (0.02) | 0.00 | (0.16) | (0.59) | (2.25) | (2.84) |
Interest Coverage |
(34.09) | (640.88) | (68.87) | (2,023.77) | (44.35) | (71.14) | (16.58) | (11.70) | (8.28) | (2.13) |
| (177.43%) | 0.00% | (112.72%) | 0.00% | (50.72%) | 0.00% | (52.69%) | (114.01%) | (202.56%) | (111.05%) | |
| (80.47%) | 0.00% | (70.99%) | 0.00% | (35.78%) | 0.00% | (36.80%) | (63.43%) | (73.59%) | (24.69%) | |
ROIC |
0.00% | 0.00% | (226.33%) | 0.00% | (113.98%) | 0.00% | (140.97%) | (475.43%) | (468.45%) | (70.71%) |
Return on Tangible Assets |
(97.57%) | (93.69%) | (97.75%) | (56.34%) | (58.64%) | (42.17%) | (43.10%) | (103.53%) | (84.61%) | (46.11%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 70.37 | 84.91 | 114.92 | 114.92 | 84.76 | 70.91 | 124.71 |
Research and Development Expense of Revenue |
501.62% | 4,153.84% | 4,356.73% | 122.34% | 159.63% | 110.93% | 121.96% | 247.27% | 341.83% | 24.81% |
Selling, General and Administrative Expense of Revenue |
168.45% | 3,493.54% | 3,700.47% | 149.03% | 179.80% | 203.40% | 203.40% | 255.84% | 582.80% | 99.28% |
Intangible Assets out of Total Assets |
0.00 | 0.09 | 0.09 | 0.09 | 0.09 | 0.06 | 0.06 | 0.06 | 0.03 | 0.02 |
Share Based Compensation of Revenue |
41.83% | 0.00% | 534.61% | 0.00% | 52.49% | 0.00% | 58.35% | 57.69% | 134.37% | 18.62% |
Graham Net Nets |
0.28 | 0.28 | 0.38 | 0.37 | 0.14 | 0.13 | 0.16 | 0.03 | 0.04 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(60.75%) | (59.09%) | (60.68%) | (59.67%) | (14.58%) | (13.81%) | (11.17%) | (10.41%) | (13.85%) | (2.35%) |
Free Cash Flow Yield |
(63.38%) | (61.65%) | (54.91%) | (54.00%) | (14.11%) | (13.37%) | (7.86%) | (5.72%) | (10.63%) | (1.35%) |
Revenue per Share |
0.44 | 0.02 | 0.02 | 0.31 | 0.26 | 0.26 | 0.26 | 0.27 | 0.18 | 1.84 |
Operating CF per Share |
(2.61) | (1.60) | (1.60) | (0.69) | (0.69) | (0.47) | (0.47) | (0.64) | (1.19) | (0.41) |
Capex per Share |
(0.10) | 0.00 | (0.02) | 0.00 | 0.00 | 0.00 | (0.01) | (0.02) | (0.06) | (0.05) |
Free Cash Flow per Share |
(2.71) | (1.60) | (1.62) | (0.69) | (0.69) | (0.47) | (0.48) | (0.66) | (1.25) | (0.47) |
Cash per Share |
3.02 | 1.93 | 1.93 | 1.16 | 1.16 | 1.53 | 1.53 | 1.29 | 2.24 | 2.22 |
Shareholders Equity per Share |
1.89 | 2.10 | 2.10 | 1.31 | 1.31 | 1.48 | 1.48 | 0.73 | 1.01 | 0.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.89 | 2.10 | 2.10 | 1.31 | 1.31 | 1.48 | 1.48 | 0.73 | 1.01 | 0.52 |
Free Cash Flow |
(50.13) | (54.14) | (54.90) | (34.04) | (34.14) | (28.59) | (29.17) | (42.85) | (98.36) | (40.02) |
Working Capital |
39.51 | 54.33 | 54.33 | 53.95 | 53.95 | 91.01 | 91.01 | 71.35 | 143.32 | 137.63 |
Capital Expenditures |
(1.85) | (0.75) | (0.75) | (0.11) | (0.11) | (0.59) | (0.59) | (1.29) | (4.94) | (4.34) |
Net Current Asset Value |
22.49 | 36.13 | 37.62 | 30.30 | 32.81 | 58.89 | 61.04 | 18.86 | 34.17 | (9.78) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.23 | 0.00 | 1.02 | 0.00 | 0.01 | 0.00 | 0.04 | 0.07 | 0.35 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.35 | 0.46 | 0.79 | 1.12 | 0.63 | 0.88 | 0.49 | 0.26 | 0.13 |
Cash ROIC |
(46.56%) | 0.00% | (37.36%) | 0.00% | (25.57%) | 0.00% | (14.32%) | (24.21%) | (26.65%) | (9.38%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 7.88 | 0.00 | 3.98 | 3.85 | 4.13 | 5.57 |
Accounts Payable Turnover |
0.24 | 0.00 | 0.07 | 0.00 | 1.26 | 0.00 | 1.75 | 1.61 | 1.93 | 3.17 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.10 |
Average Days of Payables |
1,581.73 | 416.98 | 5,734.05 | 54.07 | 129.19 | 173.69 | 280.48 | 176.43 | 291.12 | 101.38 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.96 | 656.07 |
Average Receivables |
— | — | — | 1.63 | 1.63 | 4.00 | 4.00 | 4.54 | 3.39 | 28.41 |
Average Payables |
3.37 | 3.62 | 3.62 | 2.40 | 2.40 | 1.63 | 1.63 | 1.80 | 3.04 | 4.18 |
Average Inventory |
— | — | — | — | — | — | — | — | — | 12.02 |
Average Assets |
59.13 | 84.94 | 84.19 | 97.89 | 96.63 | 112.54 | 111.46 | 123.77 | 174.32 | 279.12 |
Average Common Equity |
26.82 | 53.02 | 53.02 | 68.18 | 68.18 | 77.84 | 77.84 | 68.86 | 63.34 | 62.06 |
Columns are period end dates · fundamentals updated 26 Oct 2026